Guinness Asset Management’s Edwards Lifesciences EW Stock Holding History

Guinness Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$532K	Buy	5,886 +1,259	+27%	+$105K	0.01%	97
2026 Q1	$371K	Buy	+4,627	New	+$381K	0.01%	102
2025 Q4	–	Sell	-4,978	Closed	-$384K	–	147
2025 Q3	$384K	Sell	4,978 -446	-8%	-$34.8K	0.01%	104
2025 Q2	$424K	Sell	5,424 -976	-15%	-$72.8K	0.01%	85
2025 Q1	$463K	Sell	6,400 -1,214	-16%	-$86.9K	0.01%	81
2024 Q4	$564K	Sell	7,614 -1,184	-13%	-$82.9K	0.01%	83
2024 Q3	$581K	Buy	8,798 +2,737	+45%	+$199K	0.01%	80
2024 Q2	$560K	Buy	6,061 +192	+3%	+$17K	0.01%	78
2024 Q1	$561K	Hold	5,869	–	–	0.01%	82
2023 Q4	$448K	Sell	5,869 -280	-5%	-$19.5K	0.01%	96
2023 Q3	$426K	Buy	6,149 +136	+2%	+$10.9K	0.01%	94
2023 Q2	$567K	Sell	6,013 -603	-9%	-$52.4K	0.01%	86
2023 Q1	$547K	Buy	+6,616	New	+$520K	0.01%	88

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Guinness Asset Management's EW Position: Q2 2026 in Review

Guinness Asset Management increased its Edwards Lifesciences (EW) stake by 27% in Q2 2026, buying an estimated $105K and bringing the position to 5,886 shares worth $532K. The position accounts for 0.01% of the portfolio, ranked #97.

Guinness Asset Management first reported a position in EW in Q1 2023 and has held it in 13 quarters since. The position peaked at $581K in Q3 2024. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Guinness Asset Management held 5,886 shares of Edwards Lifesciences worth $532K as of Q2 2026.
Guinness Asset Management bought 1,259 Edwards Lifesciences shares in Q2 2026, an estimated $105K.
Edwards Lifesciences made up 0.01% of Guinness Asset Management's portfolio in Q2 2026, its #97 holding.
Guinness Asset Management first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 13 quarters since.
Guinness Asset Management's Edwards Lifesciences position peaked at $581K in Q3 2024.
1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Guinness Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.